Skip to main content

Annual Monitoring for Patients on Persistent Medications (MPM)

CBE ID
2371
1.4 Project
Patient Safety
Endorsed
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
E&M Cycle
Fall 2018
Is Under Review
No
1.3 Measure Description

This measure assesses the percentage of patients 18 years of age and older who received a least 180 treatment days of ambulatory medication therapy for a select therapeutic agent during the measurement year and at least one therapeutic monitoring event for the therapeutic agent in the measurement year. Report the following three rates and a total rate:

- Rate 1: Annual Monitoring for patients on angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB): At least one serum potassium and a serum creatinine therapeutic monitoring test in the measurement year.

- Rate 2: Annual monitoring for patients on diuretics: At least one serum potassium and a serum creatinine therapeutic monitoring test in the measurement year.

- Total rate (the sum of the two numerators divided by the sum of the two denominators)

    • 1.14 Numerator

      This measure is reported as two rates and a total rate.

      Rate 1: Annual monitoring for patients on ACE inhibitors or ARBs: the number of patients with at least one serum potassium and serum creatinine therapeutic monitoring test in the measurement year.



      Rate 2: Annual monitoring for patients on diuretics: the number of patients with at least one serum potassium and serum creatinine therapeutic monitoring test in the measurement year.

      Total rate: sum of the 2 numerators.

    • 1.15 Denominator

      Patients age 18 and older as of the end of the measurement year (e.g., December 31) who are on selected persistent medications (ACE Inhibitors/ARB or Diuretics.)

    • Exclusions

      Exclude patients who use hospice services or elect to use a hospice benefit any time during the measurement year, regardless of when the services began.

      Exclude patients who had an acute or nonacute inpatient encounter during the measurement year.

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Patient Safety Fall Cycle 2018
      Initial Endorsement
      Last Updated
      Removal Date